Quantum-Si Incorporated, a proteomics technology company, has announced a $50 million registered direct offering of common stock. The company has entered into a securities purchase agreement with a single institutional investor for the sale of 29,940,119 shares of common stock at a price of $1.67 per share. The offering is expected to close around July 8, 2025, pending customary closing conditions. A.G.P./Alliance Global Partners is serving as the sole placement agent for the transaction. The proceeds from this offering are intended for working capital and general corporate purposes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum-Si Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250703705354) on July 04, 2025, and is solely responsible for the information contained therein.